AstraZeneca PLC is 57.5x more valuable than LIGAND PHARMACEUTICALS INC by market capitalization ($286.27 B vs $4.97 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LGND | AZN |
|---|---|---|
| Market cap | $4.97 B | $286.27 B |
| US-listed rank | #1389 | #45 |
| Revenue (latest FY) | $268.09M | - |
| Net income (latest FY) | $124.45M | - |
| Net margin | 46.4% | - |
| P/E (trailing FY) | 40.0 | - |
| SEC filings | 2,226 | 1,004 |
AstraZeneca PLC is 57.5x more valuable than LIGAND PHARMACEUTICALS INC by market capitalization ($286.27 B vs $4.97 B).
Full pages: LIGAND PHARMACEUTICALS INC and AstraZeneca PLC, or browse the full rankings.